BACKGROUND	In the TRITON-TIMI 38 ( TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction 38 ) study prasugrel 10 mg reduced ischemic events versus clopidogrel 75 mg , but increased bleeding in VE patients .\